EP2364137 - Bibliographic data
SUSPENSION PHARMACEUTIQUE
| Last update | 10/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
NOVARTIS AG Lichtstrasse 35
4056 Basel
Suisse
|
|---|---|
| (72) Inventors |
Bhagwati P. KABRA 2205 Eagles Nest Drive
Euless
Texas 76039
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient STIERWALD, MICHAEL ET AL Novartis Pharma AG
Patent Department
Forum 1
Novartis Campus
4056 Basel
Suisse
|
| (21) Request number | EP09768284.3 |
|---|---|
| (22) Request date | 03/12/2009 |
| (11) Publication number | EP2364137 |
|---|---|
| Publication date | 29/03/2017 |
| (54) Title of the invention | SUSPENSION PHARMACEUTIQUE |
|---|---|
| (51) International classification | A61K 9/00, A61K 9/10, A61K 47/10 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 120081 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 9 -
Amount: 145 € -
Due date 02/01/2018
Surtax: 9 - Amount: 29 € - Due date 03/07/2018 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 29/03/2017 Entrée en période de grâce du brevet d'invention - Legal date 03/01/2018 Déchéance du brevet d'invention après période de grâce - Legal date 02/01/2018 |